Reuters logo
5 months ago
BRIEF-Allergan agrees to acquire Zeltiq for $2.48 bln
February 13, 2017 / 1:18 PM / 5 months ago

BRIEF-Allergan agrees to acquire Zeltiq for $2.48 bln

1 Min Read

Feb 13 (Reuters) - Allergan Plc

* Allergan has agreed to acquire Zeltiq for $56.50 per share, or $2.475 billion

* Deal for for $56.50 per share

* Allergan to acquire Zeltiq, best-in-class company in fast-growing body contouring segment, for $2.47 billion

* Acquisition of Zeltiq is immediately accretive

* Moelis & Company is acting as financial advisor to Allergan, and Debevoise & Plimpton LLP is acting as lead legal counsel Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below